Samuel Yamshon, M.D.


Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

After having several family members diagnosed with blood cancer, I was inspired to pursue a career treating lymphoma to help other patients and families affected by this difficult disease. I am a big believer in personalized medicine: that my job as a doctor is not to tell patients what to do, but to work together to find the treatments that best help them achieve their goals by fostering a close and collaborative relationship together. I work with a multi-disciplinary team to bring our patients the most innovative and effective new treatments which often means utilizing our large clinical trial program through which I can provide patients with early access to the newest therapies. My top priority is always that each and every patient entrusted to my care receives the most effective treatment that is consistent with their goals for therapy, whatever they may be. 

Biographical Info

Samuel Yamshon, M.D. is an Assistant Professor of Medicine at Weill Cornell Medicine/New York Presbyterian Hospital. Dr. Yamshon cares for patients with blood cancers with a specific focus on lymphoma and improving outcomes for patients using innovative treatments like cellular immunotherapies including CAR T-cell therapy. 

Dr. Yamshon received his B.A. from Columbia University and completed his medical training at the University of California, Davis. He returned to New York to train in Internal Medicine at Weill Cornell Medicine, where he also completed his fellowship in Hematology and Oncology. At Weill Cornell Medicine, he specializes in treating patients with lymphoma using cellular therapies including bone marrow transplantation and CAR T cell therapy, and is involved in clinical research dedicated to improving outcomes for patients with lymphoma. He has been involved in lymphoma research for over a decade, co-authoring numerous publications and several presentations at national meetings. Dr. Yamshon is also an Editorial Fellow for the journal Leukemia & Lymphoma. He has received multiple research grants including the American Society of Clinical Oncology (ASCO) Young Investigator Award and the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program. 

Board Certifications
American Board of Internal Medicine
  • M.D.
    University of California, Davis, School of Medicine
  • B.A.
    Columbia University
  • B.A.
    Jewish Theological Seminary
  • Assistant Attending Physician
    NewYork-Presbyterian Hospital
  • Assistant Professor of Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Bristol-Myers Squibb Company
Advisory/Scientific Board Member: 
Kite Pharma, Inc.
Other Interest: 
Kite Pharma, Inc.